Episode description
Top 3 takeaways
- Developments in the spinal cord stimulation market for pain heat up with regulatory approval of 2 new devices for the treatment of chronic pain.
- Medtronic faces competition as Axonics enters the market with their sacral nerve stimulation device for fecal incontinence.
- Two major announcement for the treatment of paralysis due to SCI; one from DARPA and the other from European start-up venture, GTX medical